Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study

Psychological Medicine
M HarrowR N Faull

Abstract

The prevailing standard of care in the field involves background assumptions about the importance of prolonged use of antipsychotic medications for all schizophrenia (SZ) patients. However, do all SZ patients need antipsychotics indefinitely? Are there factors that help to identify which SZ patients can enter into prolonged periods of recovery without antipsychotics? This 20-year longitudinal research studied these issues. A total of 139 early young psychotic patients from the Chicago Follow-up Study, including 70 patients with SZ syndromes and 69 with mood disorders, were assessed, prospectively, at the acute phase and then followed up six times over the next 20 years. Patients were assessed with standardized instruments for major symptoms, psychosocial functioning, personality, attitudinal variables, neurocognition and treatment. At each follow-up, 30-40% of SZ patients were no longer on antipsychotics. Starting at the 4.5-year follow-ups and continuing thereafter, SZ patients not on antipsychotics for prolonged periods were significantly less likely to be psychotic and experienced more periods of recovery; they also had more favorable risk and protective factors. SZ patients off antipsychotics for prolonged periods did not r...Continue Reading

References

Jan 1, 1978·Archives of General Psychiatry·R C BlandH Orn
Jul 1, 1978·Archives of General Psychiatry·J Endicott, R L Spitzer
Jan 1, 1978·Schizophrenia Bulletin·G E Vaillant
Mar 1, 1991·Archives of General Psychiatry·B J CaroneJ F Westermeyer
Jul 1, 1990·Archives of General Psychiatry·M HarrowH Y Meltzer
Oct 1, 1987·The American Journal of Psychiatry·W S Fenton, T H McGlashan
Dec 1, 1972·Archives of General Psychiatry·J S Strauss, W T Carpenter
Apr 1, 1966·The American Journal of Psychiatry·S LevensteinM Pollack
Jan 1, 1980·The American Journal of Psychiatry·G Chouinard, B D Jones
Dec 1, 1984·Archives of General Psychiatry·P Cohen, J Cohen
Mar 1, 1983·The Journal of Nervous and Mental Disease·E Zigler, J Levine
Mar 1, 1995·Archives of General Psychiatry·R J Baldessarini, A C Viguera
Jan 27, 1998·The Journal of Nervous and Mental Disease·J H StephensP R McHugh
Nov 24, 1999·Journal of the American Academy of Child and Adolescent Psychiatry·J McClellanA DuBose
Aug 24, 2000·European Psychiatry : the Journal of the Association of European Psychiatrists·V LehtinenE Syvälahti
Nov 4, 2000·The British Journal of Psychiatry : the Journal of Mental Science·M HarrowE W Davies
May 31, 2001·Acta Psychiatrica Scandinavica·L J Bosveld-van HaandelR J van den Bosch
Jun 5, 2001·The British Journal of Psychiatry : the Journal of Mental Science·G HarrisonD Wiersma
Nov 19, 2002·The Journal of Nervous and Mental Disease·Robyn A ReedEileen M Martin
Feb 4, 2003·The American Journal of Psychiatry·William T CarpenterRobert J Levine
Jun 11, 2003·Schizophrenia Bulletin·John R Bola, Loren R Mosher
Jan 30, 2004·Diabetes Care·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
Jul 16, 2005·Schizophrenia Bulletin·Martin HarrowEllen S Herbener
Sep 21, 2005·The New England Journal of Medicine·Jeffrey A LiebermanUNKNOWN Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators
Feb 24, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Thomas H Jobe, Martin Harrow
Apr 15, 2006·The Journal of Nervous and Mental Disease·Katherine E BurdickAnil K Malhotra
Jun 8, 2006·Psychological Medicine·N M MenezesR B Zipursky
Nov 15, 2006·Schizophrenia Bulletin·Raquel E GurWilliam S Stone
Mar 16, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anne-Noël SamahaShitij Kapur
Feb 5, 2008·Schizophrenia Research·Rajiv TandonUNKNOWN Section of Pharmacopsychiatry, World Psychiatric Association
Jul 1, 2008·Psychological Medicine·C R M DibbenP J McKenna
Jul 17, 2008·Current Psychiatry Reports·Michael A Webber, Stephen R Marder
Feb 4, 2009·Psychological Medicine·C WhiteS Lewis
Jun 6, 2009·Harvard Review of Psychiatry·Joanna Moncrieff
Dec 4, 2009·Schizophrenia Bulletin·Julie KreyenbuhlUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Dec 4, 2009·Schizophrenia Bulletin·Robert W BuchananUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Jan 21, 2010·Psychological Medicine·J Moncrieff, J Leo
Feb 10, 2010·Molecular Psychiatry·K S Kendler, M C Neale
Apr 2, 2010·The British Journal of Psychiatry : the Journal of Mental Science·David Cunningham OwensTimothy J Crow
Jul 24, 2010·Schizophrenia Bulletin·Gary Remington, Shitij Kapur

❮ Previous
Next ❯

Citations

Mar 21, 2013·Schizophrenia Bulletin·Martin Harrow, Thomas H Jobe
Apr 30, 2014·Schizophrenia Bulletin·W Wolfgang FleischhackerPeter Woodruff
Feb 18, 2016·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Kalman J KaplanKelsey Clews
Aug 28, 2014·Issues in Mental Health Nursing·Sandra P Thomas
Oct 31, 2015·European Psychiatry : the Journal of the Association of European Psychiatrists·A B ShmuklerY Zaytseva
Jul 25, 2014·Human Psychopharmacology·Takefumi SuzukiMasaru Mimura
Apr 6, 2013·International Journal of Geriatric Psychiatry·Tiina TalaslahtiEsa Leinonen
Apr 5, 2016·International Journal of Mental Health Systems·Samuel V NickelsMyrna S Rojas Valle
Sep 26, 2015·Early Intervention in Psychiatry·Georgia L StevensJacqueline Zummo
Apr 8, 2016·International Journal of Psychiatry in Clinical Practice·Stefano PorcelliAlessandro Serretti
Aug 27, 2013·Schizophrenia Research·Robert B ZipurskyDavid L Streiner
May 18, 2016·The Journal of Behavioral Health Services & Research·Caitlin G AllenAshley Wennerstrom
Jun 17, 2016·European Psychiatry : the Journal of the Association of European Psychiatrists·J M MoilanenJ Miettunen
Oct 5, 2016·Issues in Mental Health Nursing·Per BülowAlain Topor
Aug 5, 2015·PLoS Medicine·Joanna Moncrieff
Mar 18, 2016·Qualitative Health Research·Gabrielle Le GeytGillian Haddock
Mar 10, 2017·Schizophrenia Research·Regitze Sølling WilsMerete Nordentoft
Mar 2, 2017·Journal of Psychiatric and Mental Health Nursing·S McCorkindaleC R Martin
Feb 14, 2015·Journal of the American Psychiatric Nurses Association·Susie Adams
Mar 16, 2018·The Australian and New Zealand Journal of Psychiatry·Nimrod Pik
Aug 30, 2016·The Journal of Nervous and Mental Disease·Paul Richard Kauffman
Oct 10, 2018·Journal of Clinical Psychopharmacology·Hideaki TaniHiroyuki Uchida
May 20, 2017·The British Journal of Psychiatry : the Journal of Mental Science·Hiroyoshi TakeuchiGary Remington
Sep 3, 2017·The British Journal of Psychiatry : the Journal of Mental Science·Stefan Leucht, John M Davis
Mar 7, 2013·CNS Spectrums·Debbi A Morrissette, Stephen M Stahl
May 3, 2019·Journal of Psychiatric and Mental Health Nursing·Siphiwe Nxumalo NgubaneElizabeth Collier
Aug 4, 2012·The British Journal of Psychiatry : the Journal of Mental Science·Anthony P MorrisonDouglas Turkington
Dec 20, 2018·Psychological Medicine·Joanna Moncrieff, Sandra Steingard
Feb 18, 2020·European Archives of Psychiatry and Clinical Neuroscience·Maximilian HuhnStefan Leucht
Mar 12, 2016·Current Opinion in Psychiatry·Robin EmsleyLebogang Phahladira
Nov 5, 2020·The Australian and New Zealand Journal of Psychiatry·TianHong ZhangJiJun Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here